Palvella Therapeutics Inc (PVLA)
27.43 -0.18 (-0.65%) 03/20/25 [NASDAQ]
26.13 x 100 34.30 x 100
Realtime by (Cboe BZX)
26.13 x 100 34.30 x 100
Realtime - - (-) -
for Thu, Mar 20th, 2025
Results
download Want to compare other data? Select Fields| Symbol | PVLA | AZN | AMGN | GILD | VRTX |
| Company | Palvella Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 27.09 | 76.60 | 314.17 | 106.82 | 509.99 |
| High | 28.47 | 77.01 | 315.99 | 106.83 | 515.67 |
| Low | 26.53 | 76.27 | 312.24 | 104.70 | 505.49 |
| Last | 27.43 | 76.52 | 315.04 | 105.87 | 510.18 |
| Change | -0.18 | +0.20 | -0.71 | -1.64 | -2.34 |
| % Change | -0.65% | +0.26% | -0.22% | -1.53% | -0.46% |
| Volume | 69,300 | 3,194,900 | 2,049,700 | 11,281,700 | 1,064,700 |
| 20-Day Average Volume | 60,935 | 6,139,050 | 3,056,655 | 10,120,375 | 1,333,125 |
| Previous Close | 27.61 | 76.32 | 315.75 | 107.51 | 512.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 23.69 | 76.26 | 314.13 | 112.76 | 492.75 |
| 20-Day Raw Stochastic | 83.60% | 61.89% | 46.14% | 7.67% | 79.42% |
| 20-Day Relative Strength | 72.41% | 58.45% | 58.33% | 47.88% | 64.48% |
| Weighted Alpha | +8.33 | +13.20 | +13.03 | +51.53 | +23.61 |
| Today's Opinion | 100% Buy | 56% Buy | 56% Buy | 80% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 56% Buy | 80% Buy | 56% Buy |
| Last Month's Opinion | 56% Buy | 8% Sell | 24% Sell | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.92% since 03/13/25 | +0.01% since 03/13/25 | +0.77% since 03/13/25 | -6.60% since 03/13/25 | +1.44% since 03/13/25 |
| Low | 26.14 on 03/14/25 | 76.17 on 03/19/25 | 310.30 on 03/14/25 | 104.70 on 03/20/25 | 502.26 on 03/14/25 |
| High | 28.47 on 03/20/25 | 77.76 on 03/17/25 | 319.31 on 03/18/25 | 113.36 on 03/14/25 | 519.68 on 03/14/25 |
| 1-Month | |||||
| %Chg | +44.37% since 02/20/25 | +2.63% since 02/20/25 | +5.74% since 02/20/25 | -3.78% since 02/20/25 | +6.21% since 02/20/25 |
| Low | 18.05 on 02/21/25 | 73.54 on 02/21/25 | 297.19 on 02/21/25 | 104.70 on 03/20/25 | 473.51 on 02/27/25 |
| High | 29.27 on 03/13/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 3-Month | |||||
| %Chg | +127.63% since 12/20/24 | +17.09% since 12/20/24 | +19.61% since 12/20/24 | +14.37% since 12/20/24 | +28.42% since 12/20/24 |
| Low | 11.17 on 12/30/24 | 64.22 on 01/14/25 | 257.05 on 01/06/25 | 88.57 on 01/10/25 | 390.92 on 12/23/24 |
| High | 29.27 on 03/13/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | +59.11% since 09/20/24 | -2.37% since 09/20/24 | -6.62% since 09/20/24 | +26.13% since 09/20/24 | +9.74% since 09/20/24 |
| Low | 11.17 on 12/30/24 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 29.27 on 03/13/25 | 79.76 on 10/02/24 | 339.17 on 09/23/24 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 307,792 | 237,300,928 | 169,241,088 | 131,844,784 | 131,009,120 |
| Shares Outstanding, K | 11,221 | 3,101,162 | 537,205 | 1,245,346 | 256,790 |
| Annual Sales | 42,810,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -24,540,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -3,590,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 0.54 | 0.41 | 0.53 | 0.21 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.19 on 11/13/24 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 03/31/25 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.57 | 15.93 | 23.32 | 0.00 |